We observed significantly lower catalase mRNA expression (p < 0.01) (Fig. 3d) and significantly lower catalase protein level in sensitive CLL B-cells than in non-sensitive cells (p < 0.05) (Fig. 3e and Fig. S2E). This evidence concerns the gene CAT and B-cell chronic lymphocytic leukemia.